NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Revenue, 2025
- $727M
- YoY, 2025
- +10.1%
- 5-year CAGR
- +10.4%
- 10-year CAGR
- +21.4%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $727M | +10.1% |
| 2024 | $661M | +11.6% |
| 2023 | $592M | +16.1% |
| 2022 | $510M | +5.2% |
| 2021 | $484M | +9.0% |
| 2020 | $444M | +8.7% |
| 2019 | $409M | +47.7% |
| 2018 | $277M | +15.2% |
| 2017 | $240M | +3.6% |
| 2016 | $232M | +121.2% |
| 2015 | $105M | +13.8% |
| 2014 | $92M | +28.8% |
| 2013 | $71M | +10.2% |
| 2012 | $65M | — |